Literature DB >> 11844515

Mammographic screening: no reliable supporting evidence?

Olli S Miettinen, Claudia I Henschke, Mark W Pasmantier, James P Smith, Daniel M Libby, David F Yankelevitz.   

Abstract

Much confusion is being generated by the conclusion of a recent review that "there is no reliable evidence that screening for breast cancer reduces mortality." In that review, however, there was no appreciation of the appropriate mortality-related measure of screening's usefulness; and correspondingly, there was no estimation of the magnitude of this measure. We take this measure to be the proportional reduction in case-fatality rate, and studied its magnitude on the basis of the only valid and otherwise suitable trial. We found reliable evidence of fatality reduction, apparently substantial in magnitude.

Entities:  

Mesh:

Year:  2002        PMID: 11844515     DOI: 10.1016/S0140-6736(02)07592-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  17 in total

1.  Does mammography save lives?

Authors:  John Hoey
Journal:  CMAJ       Date:  2002-04-30       Impact factor: 8.262

2.  Screening for a cancer: thinking before rethinking.

Authors:  O S Miettinen
Journal:  Eur J Epidemiol       Date:  2010-05-11       Impact factor: 8.082

3.  Screening for coronary heart disease: cardiology through the oncology looking glass.

Authors:  D Douglas Miller; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

4.  Screening for a cancer: a sad chapter in today's epidemiology.

Authors:  Olli S Miettinen
Journal:  Eur J Epidemiol       Date:  2008-08-28       Impact factor: 8.082

5.  A different interpretation of the efficacy of lung cancer screening in the PLCO trial.

Authors:  Motoyasu Sagawa; Tomio Nakayama; Tomotaka Sobue
Journal:  Eur J Epidemiol       Date:  2015-07-22       Impact factor: 8.082

6.  Lung cancer: Low-dose CT screening - determining the right interval.

Authors:  David Yankelevitz; Claudia Henschke
Journal:  Nat Rev Clin Oncol       Date:  2016-07-12       Impact factor: 66.675

7.  Offering lung cancer screening to high-risk medicare beneficiaries saves lives and is cost-effective: an actuarial analysis.

Authors:  Bruce S Pyenson; Claudia I Henschke; David F Yankelevitz; Rowena Yip; Ellynne Dec
Journal:  Am Health Drug Benefits       Date:  2014-08

Review 8.  The importance of the regimen of screening in maximizing the benefit and minimizing the harms.

Authors:  Claudia I Henschke; Kunwei Li; Rowena Yip; Mary Salvatore; David F Yankelevitz
Journal:  Ann Transl Med       Date:  2016-04

Review 9.  Management issues for elderly patients with breast cancer.

Authors:  Martine Extermann
Journal:  Curr Treat Options Oncol       Date:  2004-04

10.  The role of effective communication to enhance participation in screening mammography: a New Zealand case.

Authors:  Margaret A Brunton
Journal:  Int J Environ Res Public Health       Date:  2009-02-24       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.